Ligand validation:3POU

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 3POU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3POU_OLC_A_344	24%	49%	0.203	0.91	1.23	0.76	1	-	0	0	56%	0.56
3POU_OLC_A_341	15%	40%	0.249	0.805	1.07	1.3	1	3	2	0	100%	1
3POU_OLC_A_343	7%	53%	0.252	0.778	1.32	0.5	1	-	4	0	64%	0.64
3POU_OLC_A_342	3%	48%	0.386	0.722	0.91	1.12	-	2	0	0	100%	1
3POX_OLC_A_356	48%	36%	0.157	0.899	1.35	1.27	4	3	2	0	100%	1
3POQ_OLC_A_351	29%	79%	0.122	0.903	0.36	0.49	-	-	0	0	32%	0.32
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.